Company profile: VBI Vaccines
1.1 - Company Overview
Company description
- Provider of novel biopharmaceutical technologies that seek to expand vaccine.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to VBI Vaccines
Medicago
HQ: Canada
Website
- Description: Provider of vaccines in Canada, leveraging proprietary plant-based Proficia and Virus-Like Particles (VLP) technologies; focuses on the research, development, production, and commercialization of vaccines, with product candidates including an H5N1 pandemic candidate.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medicago company profile →
Acceptys
HQ: United States
Website
- Description: Provider of human antibody therapies targeting cancer and infectious diseases, offering anti-cancer and anti-viral human antibodies for lung, pancreatic, gastric, and colon cancers. Founded in 2002 and based in Sparta, New Jersey.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acceptys company profile →
Telesta Therapeutics
HQ: Canada
Website
- Description: Provider of transformative human therapeutics, focused on licensing, acquisition, development, manufacturing and commercialization of novel medicines addressing major unmet medical needs, particularly in oncology; anchor product MCNA has completed a Phase III pivotal study.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Telesta Therapeutics company profile →
BlueSphere Bio
HQ: United States
Website
- Description: Provider of TCXpress technology designed to unlock the potential of personalized T-cell therapy for the treatment of cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BlueSphere Bio company profile →
Thallion Pharmaceuticals
HQ: Canada
Website
- Description: Provider of biotechnology-based pharmaceutical development in infectious disease and oncology, currently emphasizing treatment for Shigatoxin-producing E. coli (STEC) bacterial infections; leading product candidate is Shigamabs®, a dual antibody.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Thallion Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for VBI Vaccines
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to VBI Vaccines
2.2 - Growth funds investing in similar companies to VBI Vaccines
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for VBI Vaccines
4.2 - Public trading comparable groups for VBI Vaccines
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →